Trial Outcomes & Findings for Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community (NCT NCT06289192)

NCT ID: NCT06289192

Last Updated: 2025-09-10

Results Overview

Acceptability and Feasibility will be assessed by the number of participants who complete intervention and surveys

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

5 participants

Primary outcome timeframe

3 months

Results posted on

2025-09-10

Participant Flow

Participant milestones

Participant milestones
Measure
Smoking Cessation Intervention
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months.
Overall Study
STARTED
5
Overall Study
COMPLETED
5
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months.
Age, Customized
<50 years
0 Participants
n=5 Participants
Age, Customized
>=50 years
5 Participants
n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
4 Participants
n=5 Participants
Race (NIH/OMB)
White
1 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Current tobacco use
5 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 3 months

Acceptability and Feasibility will be assessed by the number of participants who complete intervention and surveys

Outcome measures

Outcome measures
Measure
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months. C-Raven Virtual Tobacco Cessation Counseling: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete. Nicotine Replacement Product: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges. Community Health Worker: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed. Lung Cancer Screening: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
Acceptability and Feasibility as Assessed by the Number of Participants Who Complete Intervention and Surveys
Intervention completed
5 Participants
Acceptability and Feasibility as Assessed by the Number of Participants Who Complete Intervention and Surveys
All surveys completed
5 Participants

PRIMARY outcome

Timeframe: Baseline, 1 month, 3 months

Acceptability and Feasibility will be assessed by barriers to screening

Outcome measures

Outcome measures
Measure
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months. C-Raven Virtual Tobacco Cessation Counseling: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete. Nicotine Replacement Product: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges. Community Health Worker: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed. Lung Cancer Screening: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
Acceptability and Feasibility as Assessed by Barriers to Screening
Barriers to LDCT Screening, Baseline
25.2 barriers
Standard Deviation 8.6
Acceptability and Feasibility as Assessed by Barriers to Screening
Barriers to LDCT Screening, 1 Month
28.6 barriers
Standard Deviation 14.4
Acceptability and Feasibility as Assessed by Barriers to Screening
Barriers to LDCT Screening, 3 Months
31.8 barriers
Standard Deviation 14.7

SECONDARY outcome

Timeframe: 3 months

Number of participants that start using NRTs during the study period

Outcome measures

Outcome measures
Measure
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months. C-Raven Virtual Tobacco Cessation Counseling: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete. Nicotine Replacement Product: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges. Community Health Worker: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed. Lung Cancer Screening: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
Number of Participants That Uptake Nicotine Replacement Therapy
4 Participants

SECONDARY outcome

Timeframe: 3 months

Total number of interactions with CHW across all participants

Outcome measures

Outcome measures
Measure
Smoking Cessation Intervention
n=5 Participants
Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement therapies, participate in shared decision-making around lung cancer screening, and be supported by a community health worker. Participants will be followed for a total of 3 months. Assessments will be conducted at baseline, 1 month, and 3 months. C-Raven Virtual Tobacco Cessation Counseling: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete. Nicotine Replacement Product: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges. Community Health Worker: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed. Lung Cancer Screening: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
Participant Engagement With Community Health Worker (CHW) as Assessed by Number of CHW Interactions
60 CHW interactions

Adverse Events

Smoking Cessation Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Alejandra Ellison-Barnes

Johns Hopkins University

Phone: n/a

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place